Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Eisner, F; Pichler, M; Goletz, S; Stoeger, H; Samonigg, H.
A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options.
J Clin Pathol. 2015; 68(12):1044-1046 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Eisner Florian
Pichler Martin
Samonigg Hellmut
Stoeger Herbert
Altmetrics:

Dimensions Citations:

Plum Analytics:
Number of Figures: 2
| |
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Antineoplastic Agents - therapeutic use
CHO Cells -
Colorectal Neoplasms - drug therapy
Colorectal Neoplasms - pathology
Colorectal Neoplasms - surgery
Cricetinae -
Cricetulus -
Disease-Free Survival -
Female -
Gene Expression Regulation, Neoplastic -
Humans -
Liver Neoplasms - secondary
Lung Neoplasms - secondary
Middle Aged -
Receptor, ErbB-2 - immunology
Remission Induction -
Trastuzumab - therapeutic use

© Meduni Graz Impressum